ITMCTR2000003052Not yet recruitingPhase 1
Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19)
The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University0 sitesStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to 65 (—)
- Sex
- All
Inclusion Criteria
- •1) The confirmed patient (or legal guardian) agrees to participate in the study and signs the informed consent form;
- •2) aged 18 to 65 years;
- •3) The time interval between the onset of symptoms and random enrollment is within 8 days (the onset of symptoms is mainly based on the occurrence of fever);
- •4) Real-time fluorescent RT-PCR of respiratory specimens or blood specimens to detect patients with 2019-nCoV nucleic acid positive;
- •5) Patients were diagnosed as type 3 patients with mild, common and severe cases according to the Diagnosis and Treatment Scheme for 2019-nCoV (Trial Version 6).
Exclusion Criteria
- •1) Any situation where the solution cannot be carried out safely;
- •2) Allergic constitution, allergic to one or more foods or drugs;
- •3) Severe basic diseases affecting survival, including uncontrolled clinically significant heart, lung, kidney, digestive, hematological, neuropsychiatric diseases, immune diseases, metabolic diseases or malignant tumors, severe malnutrition;
- •4) pregnant or lactating women;
- •5) The patient may be transferred to a non-participating hospital within 72 hours;
- •6) Those who have continued to use immunosuppressive agents or organ transplants in the past 6 months;
- •7) Within 15 days before enrollment, during the hospitalization period, any patient who is being treated with antiviral drugs other than this program during treatment;
- •8) People who cannot cooperate with mental state, suffer from mental illness, have no self-control, and cannot express clearly;
- •9) History of HBV, HCV, TPPA, HIV, and pancreatitis before infection;
- •10) Those who are participating in other clinical trials.
Investigators
Similar Trials
Not yet recruiting
Phase 3
To compare the effect of changalamparandadi kashaya with rasnasapthakam kashaya in knee osteoarthritis.CTRI/2023/08/056815imitha B
Not yet recruiting
Not Applicable
Effect of Singhamrit ghrita on Diabetes mellitus type 2CTRI/2022/10/046301Madan Mohan Malviya Government Ayurved college,Udaipur
Completed
Not Applicable
Gandhaka Kalpa Efficacy in managing Prathama Patalagata Timira in special reference to Myopia.CTRI/2021/11/037816Dr A Mallikarjun30
Recruiting
Phase 3
Effect of Crataegus Monogyna in hypertension and associated sleep disorderIRCT20180225038859N1Zanjan University of Medical Sciences60
Not yet recruiting
Phase 2
Agnikarma in disc prolapse.CTRI/2022/11/047012Shalu mol S